The results are discussed in terms of expanding what is known about the potential tumor biology and clinical implications of CSPG4-related impact on malignant invasion during early phases of melanoma progression.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1007/s12195-025-00882-x. This evidence concerns the gene CSPG4 and melanoma.